Literature DB >> 21808933

Consumption of fish and Alzheimer's disease.

W Newton1, A McManus.   

Abstract

Alzheimer's Disease (AD) has been described as "one of the most disabling and burdensome health conditions worldwide" and is responsible for approximately 70% of dementia in the elderly. Based on the current prevalence of AD, an aging world population and the associated projected health care requirements, it is estimated that by 2050, the prevalence of AD will reach 104 million with around 43% requiring ongoing health care. If the onset of AD can be reduced by as little as one year, the prevalence could be reduced by 10%. There is substantial commonality in research findings to date around the positive influence of seafood consumption in reducing the risk of dementia and AD. Emerging concern about the sustainability of global fisheries supports the recommendation of selective consumption of sustainable wild caught and increased emphasis on production of farmed fish supplies to meet consumption needs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21808933     DOI: 10.1007/s12603-011-0065-x

Source DB:  PubMed          Journal:  J Nutr Health Aging        ISSN: 1279-7707            Impact factor:   4.075


  8 in total

1.  The importance of fish and docosahexaenoic acid in Alzheimer disease.

Authors:  William E Connor; Sonja L Connor
Journal:  Am J Clin Nutr       Date:  2007-04       Impact factor: 7.045

2.  Global prevalence of dementia: a Delphi consensus study.

Authors:  Cleusa P Ferri; Martin Prince; Carol Brayne; Henry Brodaty; Laura Fratiglioni; Mary Ganguli; Kathleen Hall; Kazuo Hasegawa; Hugh Hendrie; Yueqin Huang; Anthony Jorm; Colin Mathers; Paulo R Menezes; Elizabeth Rimmer; Marcia Scazufca
Journal:  Lancet       Date:  2005-12-17       Impact factor: 79.321

3.  Forecasting the global burden of Alzheimer's disease.

Authors:  Ron Brookmeyer; Elizabeth Johnson; Kathryn Ziegler-Graham; H Michael Arrighi
Journal:  Alzheimers Dement       Date:  2007-07       Impact factor: 21.566

4.  Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study.

Authors:  Ernst J Schaefer; Vanina Bongard; Alexa S Beiser; Stefania Lamon-Fava; Sander J Robins; Rhoda Au; Katherine L Tucker; David J Kyle; Peter W F Wilson; Philip A Wolf
Journal:  Arch Neurol       Date:  2006-11

5.  Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease.

Authors:  M Söderberg; C Edlund; K Kristensson; G Dallner
Journal:  Lipids       Date:  1991-06       Impact factor: 1.880

6.  Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease.

Authors:  Martha Clare Morris; Denis A Evans; Julia L Bienias; Christine C Tangney; David A Bennett; Robert S Wilson; Neelum Aggarwal; Julie Schneider
Journal:  Arch Neurol       Date:  2003-07

7.  A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice.

Authors:  G W Arendash; M T Jensen; N Salem; N Hussein; J Cracchiolo; A Dickson; R Leighty; H Potter
Journal:  Neuroscience       Date:  2007-08-14       Impact factor: 3.590

Review 8.  Fish, docosahexaenoic acid and Alzheimer's disease.

Authors:  S C Cunnane; M Plourde; F Pifferi; M Bégin; C Féart; P Barberger-Gateau
Journal:  Prog Lipid Res       Date:  2009-04-10       Impact factor: 16.195

  8 in total
  1 in total

Review 1.  Unified theory of Alzheimer's disease (UTAD): implications for prevention and curative therapy.

Authors:  Michael Nehls
Journal:  J Mol Psychiatry       Date:  2016-07-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.